Neuronal NO synthase mediates plenylephrine induced cardiomyocyte hypertrophy through facilitation of NFAT-dependent transcriptional activity
Neuronal nitric oxide synthase (NOS1) has been consistently shown to be the predominant isoform of NOS and/or NOS-derived NO that may be involved in the myocardial remodeling including cardiac hypertrophy. However, the direct functional contribution of NOS1 in this process remains to be elucidated....
Main Authors: | Xavier Loyer, Caroline Dubroca, Maxime Branchereau, Graziellia Griffith, Luis Garcia, Christophe Heymes |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | Biochemistry and Biophysics Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580818302231 |
Similar Items
-
NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity
by: Xin Zhang, et al.
Published: (2020-08-01) -
Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway
by: Jung Joo Yoon, et al.
Published: (2020-12-01) -
How does NFAT3 regulate the occurrence of cardiac hypertrophy?
by: Wang Hui, et al.
Published: (2023-10-01) -
Myocardial Hypertrophy and Fibrosis Are Associated with Cardiomyocyte Beta-Catenin and TRPC6/Calcineurin/NFAT Signaling in Spontaneously Hypertensive Rats with 5/6 Nephrectomy
by: Evdokia Bogdanova, et al.
Published: (2021-04-01) -
Transcriptional Regulation of TMP21 by NFAT
by: Xia Kun, et al.
Published: (2011-03-01)